Trial Profile
A study investigating the therapeutic effect of vonoprazan on the patients with proton pump inhibitor resistant eosinophilic esophagitis
Status:
Discontinued
Phase of Trial:
Phase II
Latest Information Update: 22 Aug 2019
Price :
$35
*
At a glance
- Drugs Vonoprazan (Primary)
- Indications Eosinophilic oesophagitis
- Focus Therapeutic Use
- 20 Aug 2019 Status changed from recruiting to discontinued.
- 28 May 2016 New trial record